Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

In this guide you will find:

• Evidence that humanized NSG™ mice can support the growth of allogeneic human tumors
• Human tumors respond to standard-of-care chemotherapeutics and to immune check-point inhibitors clinically proven to initiate cytotoxic activity towards the tumor
• Tumor-bearing, humanized NSG™ mice are a new and valuable preclinical testing platform for immuno-oncology

To request a PDF copy please click here.